Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22334
Abstract: The purpose of this study was to investigate the antitumor activity of regorafenib and sorafenib in preclinical models of HCC and to assess their mechanism of action by associated changes in protein expression in a… read more here.
Keywords: regorafenib sorafenib; sorafenib preclinical; versus; preclinical models ... See more keywords